Two additional cases of metformin-associated encephalopathy in patients with end-stage renal disease undergoing hemodialysis

Hemodialysis International

Volumn 17, Issue 1, 2013, Pages 111-115

  Kang, Yeo Jin ^a   Bae, Eun Jin ^a   Seo, Jong Woo ^a   Jeon, Dae Hong ^a   Cho, Hyun Seop ^a   Kim, Hyun Jung ^a   Chang, Se Ho ^a   Park, Dong Jun ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Chronic kidney disease; Encephalopathy; Hemodialysis; Intoxication; Metformin

Indexed keywords

AMLODIPINE; ASCORBIC ACID; CALCIUM CARBONATE; GLICLAZIDE; HEMOGLOBIN A1C; IRON POLYMALTOSE; METFORMIN; OLMESARTAN; SITAGLIPTIN; VALSARTAN; VITAMIN B GROUP;

ABDOMINAL DISCOMFORT; ADULT; ANOREXIA; ARTICLE; BASAL GANGLION; BRAIN DISEASE; CASE REPORT; CHRONIC KIDNEY DISEASE; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; GAIT DISORDER; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; TREATMENT DURATION; WEAKNESS;

BRAIN DISEASES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; METFORMIN; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84872654809     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00698.x     Document Type: Article

References (17)

1. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes care. 2009; 32:S13-S61.
2. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352:854-865.
3. Bolen S, Feldman L, Vassy J, etal. Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007; 147:386-399.
4. Latau JD, Race JM. Lactic acidosis in metformin therapy. Drugs. 1999; 58:75-82.
5. Ben-Ami H, Nagachandran P, Mendelson A, Edoute Y. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med. 1999; 159:281-284.
6. Rasuli P, Hammond DI. Metformin and contrast media: Where is the conflict? Can Assoc Radiol J. 1998; 49:161-166.
7. Chan KA, Truman A, Gurwitz JH, etal. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. Arch Intern Med. 2003; 163:728-734.
8. Jung EY, Cho HS, Seo JW, etal. Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin. Hemodial Int. 2009; 13:172-175.
9. Holstein A, Nahrwold D, Hinze S, Egberts EH. Contra-indication to metformin therapy are largely disregarded. Diabet Med. 1999; 16:692-696.
10. American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care. 2010; 33:S11-S61.
11. Nathan DM, Buse JB, Davidson MB, etal. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009; 32:193-203.
12. Rachmani R, Slavachevski I, Levi Z, Zadok B, Kedar Y, Ravid M. Metformin in patients with type 2 diabetes mellitus: Reconsideration of traditional contraindications. Eur J Intern Med. 2002; 13:428-433.
13. Lim VC, Sum CF, Chan ES, Yeoh LY, Lee YM, Lim SC. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function. Int J Clin Pract. 2007; 61:1829-1833.
14. Connolly V, Kesson CM. Metformin treatment in NIDDM patients with mild renal impairment. Postgrad Med J. 1996; 72:352-354.
15. Roussel R, Travert F, Pasquet B, etal. Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med. 2010; 170:1892-1899.
16. Vander T, Hallevy H, Ifergane G, Herishanu YO. Metformin-induced encephalopathy without lactic acidosis. Diabet Med. 2004; 21:194-195.
17. Bailey CJ. Biguanides and NIDDM. Diabetes Care. 1992; 15:755-772.